OI
RMD icon

Oakbrook Investments’s ResMed RMD Stock Holding History

Oakbrook Investments’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-13,300
Closed -$1.8M – 620
2019
Q3 		$1.8M Sell
13,300
-1,800
-12% -$236K 0.12% 125
2019
Q2 		$1.84M Buy
15,100
+125
+0.8% +$13.8K 0.11% 140
2019
Q1 		$1.56M Buy
14,975
+7,500
+100% +$774K 0.09% 166
2018
Q4 		$851K Buy
+7,475
New +$801K 0.06% 261

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Oakbrook Investments's RMD Position: Q4 2019 in Review

Oakbrook Investments sold out of ResMed (RMD) in Q4 2019, closing a stake of 13,300 shares — an estimated $1.8M sold.

Oakbrook Investments first reported a position in RMD in Q4 2018 and held it in 4 quarters. The position peaked at $1.84M in Q2 2019. 559 funds tracked by Wall St. Rank hold RMD as of Q4 2019.

  • Oakbrook Investments reported no remaining ResMed position as of Q4 2019 after selling out during the quarter.
  • Oakbrook Investments sold 13,300 ResMed shares in Q4 2019, an estimated $1.8M.
  • Oakbrook Investments first reported a position in ResMed in Q4 2018 and held it in 4 quarters.
  • Oakbrook Investments's ResMed position peaked at $1.84M in Q2 2019.
  • 559 funds tracked by Wall St. Rank held ResMed as of Q4 2019.

Based on Oakbrook Investments's 13F filing for Q4 2019, filed 6 Feb 2020.